Completed PHASE4 INTERVENTIONAL NCT00106821

Efficacy of Tiotropium in Patients of African Descent With Chronic Obstructive Pulmonary Disease

An 8 Week Randomized, Placebo Controlled, Double-blind Study to Assess the Efficacy of Tiotropium Inhalation Capsules in Patients of African Descent With Chronic Obstructive Pulmonary Disease

Sponsor: Boehringer Ingelheim

Conditions Pulmonary Disease, Chronic Obstructive

Interventions Tiotropium Bromide Inhalation Powder

Updated 6 times since 2017 Last updated: Oct 31, 2013 Started: Jun 30, 2004 Primary completion: Aug 31, 2005

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE4 trial investigates Pulmonary Disease, Chronic Obstructive and is currently completed. Boehringer Ingelheim leads this study, which shows 6 recorded versions since 2004 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

6 versions recorded

Sep 2025 — Present [monthly]

Completed PHASE4
Sep 2024 — Sep 2025 [monthly]

Completed PHASE4
Jul 2024 — Sep 2024 [monthly]

Completed PHASE4
Jan 2021 — Jul 2024 [monthly]

Completed PHASE4
Jun 2018 — Jan 2021 [monthly]

Completed PHASE4

▶ Show 1 earlier version

Jan 2017 — Jun 2018 [monthly]

Completed PHASE4

First recorded

Jun 2004

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Boehringer Ingelheim

Data source: Boehringer Ingelheim

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

Birmingham, United States , Charleston, United States , Greenville, United States , Houston, United States , Los Angeles, United States , New Orleans, United States , Panama City, United States , Philadelphia, United States , Saint Petersberg, United States , Sepulveda, United States and 5 more locations